164 related articles for article (PubMed ID: 38474362)
1. Neoadjuvant Radiochemotherapy Alters the Immune and Metabolic Microenvironment in Oral Cancer-Analyses of CD68, CD163, TGF-β1, GLUT-1 and HIF-1α Expressions.
Weber M; Ries J; Braun K; Wehrhan F; Distel L; Geppert C; Lutz R; Kesting M; Trumet L
Cells; 2024 Feb; 13(5):. PubMed ID: 38474362
[TBL] [Abstract][Full Text] [Related]
2. SUVmax of FDG-PET correlates with the effects of neoadjuvant chemoradiotherapy for oral squamous cell carcinoma.
Miyawaki A; Ikeda R; Hijioka H; Ishida T; Ushiyama M; Nozoe E; Nakamura N
Oncol Rep; 2010 May; 23(5):1205-12. PubMed ID: 20372831
[TBL] [Abstract][Full Text] [Related]
3. Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial.
Kartini D; Taher A; Panigoro SS; Setiabudy R; Jusman SW; Haryana SM; Abdullah M; Rustamadji P; Purwanto DJ; Sutandyo N; Suroyo I; Siregar BH; Maruli H; Sungkar S
J Egypt Natl Canc Inst; 2020 Feb; 32(1):12. PubMed ID: 32372215
[TBL] [Abstract][Full Text] [Related]
4. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
5. Improving function of cytotoxic T-lymphocytes by transforming growth factor-β inhibitor in oral squamous cell carcinoma.
Kondo Y; Suzuki S; Takahara T; Ono S; Goto M; Miyabe S; Sugita Y; Ogawa T; Ito H; Satou A; Tsuzuki T; Yoshikawa K; Ueda R; Nagao T
Cancer Sci; 2021 Oct; 112(10):4037-4049. PubMed ID: 34309966
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analyses of paraffin-embedded sections after primary surgery or trimodality treatment in esophageal carcinoma.
Igbo BT; Linge A; Frosch S; Suckert T; Stolz-Kieslich L; Löck S; Kumaravadivel MS; Welsch T; Weitz J; Sommer U; Aust D; Troost EGC
Clin Transl Radiat Oncol; 2022 Sep; 36():106-112. PubMed ID: 35993091
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation of oral leukoplakia is associated with macrophage polarization.
Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Öztürk H; Neubauer K; Wickenhauser C; Kesting M; Ries J
J Transl Med; 2020 Jan; 18(1):11. PubMed ID: 31910881
[TBL] [Abstract][Full Text] [Related]
9. PFC@O
Lan Z; Zou KL; Cui H; Chen H; Zhao YY; Yu GT
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675491
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Chemotherapy Induces IL34 Signaling and Promotes Chemoresistance via Tumor-Associated Macrophage Polarization in Esophageal Squamous Cell Carcinoma.
Nakajima S; Mimura K; Saito K; Thar Min AK; Endo E; Yamada L; Kase K; Yamauchi N; Matsumoto T; Nakano H; Kanke Y; Okayama H; Saito M; Neupane P; Saze Z; Watanabe Y; Hanayama H; Hayase S; Kaneta A; Momma T; Ohki S; Ohira H; Kono K
Mol Cancer Res; 2021 Jun; 19(6):1085-1095. PubMed ID: 33674443
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of macrophage polarization in early stage oral squamous cell carcinomas.
Weber M; Iliopoulos C; Moebius P; Büttner-Herold M; Amann K; Ries J; Preidl R; Neukam FW; Wehrhan F
Oral Oncol; 2016 Jan; 52():75-84. PubMed ID: 26728105
[TBL] [Abstract][Full Text] [Related]
12. The involvement of hypoxia-inducible factor-1alpha in the susceptibility to gamma-rays and chemotherapeutic drugs of oral squamous cell carcinoma cells.
Sasabe E; Zhou X; Li D; Oku N; Yamamoto T; Osaki T
Int J Cancer; 2007 Jan; 120(2):268-77. PubMed ID: 17066447
[TBL] [Abstract][Full Text] [Related]
13. Overcoming chemotherapy resistance using pH-sensitive hollow MnO
Zhou ZH; Liang SY; Zhao TC; Chen XZ; Cao XK; Qi M; Huang YY; Ju WT; Yang M; Zhu DW; Pang YC; Zhong LP
J Nanobiotechnology; 2021 May; 19(1):157. PubMed ID: 34039370
[TBL] [Abstract][Full Text] [Related]
14. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy.
Koda M; Kanczuga-Koda L; Sulkowska M; Surmacz E; Sulkowski S
BMC Cancer; 2010 Jun; 10():320. PubMed ID: 20569445
[TBL] [Abstract][Full Text] [Related]
15. Influence of tumor cell-derived TGF-β on macrophage phenotype and macrophage-mediated tumor cell invasion.
Maldonado LAG; Nascimento CR; Rodrigues Fernandes NA; Silva ALP; D'Silva NJ; Rossa C
Int J Biochem Cell Biol; 2022 Dec; 153():106330. PubMed ID: 36343916
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET.
Grönroos TJ; Lehtiö K; Söderström KO; Kronqvist P; Laine J; Eskola O; Viljanen T; Grénman R; Solin O; Minn H
BMC Cancer; 2014 Nov; 14():876. PubMed ID: 25421331
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Role of CD68
Chohan MH; Perry M; Laurance-Young P; Salih VM; Foey AD
Br J Biomed Sci; 2023; 80():11065. PubMed ID: 37397243
[No Abstract] [Full Text] [Related]
18. Correlation of metabolism/hypoxia markers and fluorodeoxyglucose uptake in oral squamous cell carcinomas.
Yamada T; Uchida M; Kwang-Lee K; Kitamura N; Yoshimura T; Sasabe E; Yamamoto T
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Apr; 113(4):464-71. PubMed ID: 22676927
[TBL] [Abstract][Full Text] [Related]
19. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia.
Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H
J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892
[TBL] [Abstract][Full Text] [Related]
20. A two-arm multicenter phase II trial of one cycle chemoselection split-dose docetaxel, cisplatin and 5-fluorouracil (TPF) induction chemotherapy before two cycles of split TPF followed by curative surgery combined with postoperative radiotherapy in patients with locally advanced oral and oropharyngeal squamous cell cancer (TISOC-1).
Inhestern J; Schmalenberg H; Dietz A; Rotter N; Maschmeyer G; Jungehülsing M; Grosse-Thie C; Kuhnt T; Görner M; Sudhoff H; Wittekindt C; Guntinas-Lichius O
Ann Oncol; 2017 Aug; 28(8):1917-1922. PubMed ID: 28498880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]